Usana Health Sciences (Usana Health Sciences) Debt-to-Asset

: 0.01 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

Usana Health Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $8.1 Mil. Usana Health Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.0 Mil. Usana Health Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $632.8 Mil. Usana Health Sciences's debt to asset for the quarter that ended in Dec. 2023 was 0.01.

Usana Health Sciences Debt-to-Asset Historical Data

The historical data trend for Usana Health Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.02

0.01

Usana Health Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset																0.01	-	-	-	0.01

Competitive Comparison

For the Packaged Foods subindustry, Usana Health Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Usana Health Sciences Debt-to-Asset Distribution

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's Debt-to-Asset falls into.

Usana Health Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Usana Health Sciences's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(8.064	+	0)	/	632.757
	=	0.01

Usana Health Sciences's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(8.064	+	0)	/	632.757
	=	0.01

Usana Health Sciences (NYSE:USNA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Usana Health Sciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Usana Health Sciences (Usana Health Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (NYSE:USNA) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

USJ:Germany

Address

3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120

Website

http://www.usanahealthsciences.com

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Executives

John Turman Fleming	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Gilbert A Fuller	officer: CFO and Executive V.P.	55 WANDERWOOD WAY, SANDY UT 84092
Frederic J Winssinger	director	2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018
David Mulham Mulham	officer: Chief Field Development Office	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Paul A. Jones	officer: CFO	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Xia Ding	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Daniel A. Macuga	officer: Chief Communications Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Jim Brown	officer: Chief Production Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Brent Neidig	officer: CO & Man. Dir. of China	3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120
J Scott Nixon	director	757 EAST SOUTH TEMPLE, SUITE 150, SALT LAKE CITY UT 84102
Kevin Guest	officer: E.V.P. of Marketing	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Joshua Foukas	officer: Chief Legal Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120
G Doug Iiekking	officer: VP of Finance	C/O USANA HEALTH SCIENCES INC, 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
Walter Noot	officer: Chief Information Officer	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Robert A Sinnott	officer: Chief Scientific Officer	400 55 WATER STREET, VANCOUVER A1 V6B1A1